Microinvasive carcinoma of the cervix
Authors:
Abstract
Background. Microinvasive carcinoma of the cervix (MIC) has been poorly defined in the past and is still a focus of persistent controversy. In 1985, the International Federation of Gynecology and Obstetrics (FIGO) defined Stage IA as “preclinical invasive carcinoma, diagnosed by microscopy only,” subdividing it into Stage IA1 or “minimal microscopic stromal invasion,” and Stage IA2 or “tumor with invasive component 5 mm or less in depth taken from the base of the epithelium and 7 mm or less in horizontal spread.” In 1974, the Society of Gynecologic Oncologists (SGO) defined MIC as any lesion with a depth of invasion of 3 mm or less from the base of the epithelium, without lymphatic or vascular space invasion. Methods. To assess the risk of lymph node metastasis and treatment failures, pathologic material and clinical data on 370 patients with Stage I carcinoma of the cervix, who were treated by radical hysterectomy and pelvic‐aortic node dissection, were reviewed. Histopathologic analysis of tumors was based on a uniform format, including measurement of the maximum depth of invasion, the width and length of the horizontal tumor spread, invasive growth pattern, cell type, tumor grade, and lymphatic or vascular space involvement. Results. Of the 370 patients, 110 had a depth of invasion of 5 mm or less. Of these, 54 patients fulfilled the SGO definition of MIC; 42, the new FIGO Stage IA2 definition; and 27, both definitions. None of the patients with MIC, as defined by either the SGO or the new FIGO Stage IA2, had lymph node metastases or tumor recurrence. These data support the conclusion that MIC, defined by either the SGO or FIGO definitions, have a low risk for lymph node metastasis or recurrent carcinoma. A review of the literature indicated a recurrence rate for Stage IA2 of 4.2%. In addition to depth of invasion, lymph vascular space invasion is a better predictor of lymph node metastasis and recurrence than the surface dimension. Conclusions.The authors recommend adoption of the SGO definition of MIC. Patients with a depth of invasion of 3 mm or less without lymph vascular space invasion safely can be treated conservatively.Keywords
This publication has 13 references indexed in Scilit:
- A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1989
- Mikroinvasives Karzinom der Cervix uteri Stadium Ia-Ergebnisse einer multizentrischen klinikbezogenen AnalyseGeburtshilfe und Frauenheilkunde, 1989
- Widespread lymph node metastases in a patient with microinvasive cervical carcinomaGynecologic Oncology, 1989
- The problem of stage Ia (FIGO, 1985) carcinoma of the uterine cervixGynecologic Oncology, 1989
- Follow-up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma)Gynecologic Oncology, 1989
- Management of Stage IA carcinoma of the cervixAmerican Journal of Obstetrics and Gynecology, 1985
- Microinvasive carcinoma of the uterine cervixCancer, 1980
- A new proposal regarding criteria for Stage Ia cancer in the uterine cervixGynecologic Oncology, 1979
- Early squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1978
- Early squamous cell carcinoma of the uterine cervix II. Clinical results of a cooperative study in the management of 419 patients with early stromal invasion and microcarcinomaGynecologic Oncology, 1978